Overview

Comparison Between Intrathecal and Intravenous Dexmedetomidine

Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
0
Participant gender:
All
Summary
A prospective, randomized, comparative controlled clinical trial, aiming to compare the use of intrathecal dexmedetomidine by intravenous dexmedetomidine in concern of the first request to analgesia. The secondary end-points were the total postoperative analgesic consumption as well as the VAS.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Suez Canal University
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- ASA I-II patients

- age 18-65 years

- scheduled for lower limb surgery

- spinal anaesthesia

Exclusion Criteria:

- patients with coagulopathy

- infection at the site of lumbar puncture

- beta-blockers or calcium channel blockers usage

- hypersensitivity to Bupivacaine or Dexmedetomidine

- any other contra-indications for spinal anaesthesia.